---
layout: post
title: "HYPERLACTATEMIA AS PREDICTOR MORBIDITY IN ACUTE MYOCARDIAL INFARCTION"
author: "Ketut Erna Bagiari, Ketut Rina, Ida Sri Iswari"
description: "Acute myocardial infarction AMI still have high prevalence of morbidities and mortality and thereforewe need a reliable marker that represent the severity of the dise"
categories: medicina
canonical_url: https://jurnal.harianregional.com/medicina/id-18083
comments: true
citation_abstract_html_url: "https://jurnal.harianregional.com/medicina/id-18083"
citation_pdf_url: "https://jurnal.harianregional.com/medicina/full-18083"
tags:

---

## Authors:
Ketut Erna Bagiari, Ketut Rina, Ida Sri Iswari

## Abstract:
"Acute myocardial infarction (AMI) still have high prevalence of morbidities and mortality, and thereforewe need a reliable marker that represent the severity of the disease. Degree of hypoperfusion canmeasure by lactate production. Lactate is a byproduct of anaerob metabolism and marker of tissuehypoperfusion.The prognostic role of lactate for morbidity in patients with AMI has not been elucidatedso far. There is no previous study to determine the role of hyperlactatemia as predictor of morbidity inAMI patients in Indonesia.The aim of this study was to assess whether lactate is an independentprognostic predictor morbidity patient with AMI in Sanglah Hospital, Denpasar. This was anobservational cohort prospective study, which enrolled 70 AMI patients by consecutive sampling. Wemeasured capillary lactate level three times, at first admission, 2h, and 24 h after admission, usingrapid point-of-care analyzer accutrend lactatemeter. We observed for morbidities and the subsets(cardiogenic shock, heart failure, arrhythmia) during hospitalization. The result of this study were theAMI patients with hyperlactatemia have an almost 3-fold [hazard ratio (HR) =2.578,95%confidenceinterval (CI)=1.278 to 5.199, P=0.008)increased risk of morbidity, a 15-fold increased risk ofcardiogenicshock of(HR =15.231, 95% CI =1.848 to 700.579,P=0.0014) and a 5-fold increased risk of heart failure(HR=5.269, 95% CI =1.913 to 15.796,P=0.0002) compared with subject without hyperlactatemia. Onthe other hand, hyperlactatemia was not associated as a predictor of arrhythmia (HR = 1.35, 95% CI =0.344 to 4.627,P=0.3051).Hyperlactatemia is an independent predictor of morbidity, cardiogenic shock,and heart failure in AMI patients. On the other hand, hyperlactatemia is not an independent predictorof arrhythmia in AMI patients. [MEDICINA 2015;46:71-6].Prevalensi morbiditas dan mortalitas pada infark miokard akut (IMA) masih cukup tinggi, dengandemikian dibutuhkan biomarker yang reliabel menggambarkan keparahan penyakit. Derajat hipoperfusidapat dinilai dengan mengukur produksi laktat.Laktat merupakan produk metabolisme anaerob danpenanda hipoperfusi jaringan. Peran laktat sebagai prognosis morbiditas pada pasien IMA hinggasaat ini belum diketahui. Hingga saat ini belum ada studi untuk menentukan peran hiperlaktasemiasebagai prediktor morbiditas IMA di Indonesia. Studi ini dilakukan untuk menilai apakah laktatsebagai prediktor independen prognosis morbiditas pasien IMA di Rumah Sakit Sanglah, Denpasar.Penelitian ini merupakan studi observasional kohort prospektif yang melibatkan 70 pasien IMA dengancara konsekutif. Dilakukan tiga kali pemeriksaan kadar laktat kapiler secara serial yaitu saat pertamakali masuk rumah sakit, 2 jam, dan 24 jam setelahnya dengan menggunakan alat analisis cepataccutrend lactatemeter. Selama perawatan diamati adanya morbiditas, syok kardiogenik, gagal jantung,dan aritmia. Pada penelitian didapatkan hiperlaktasemia pada pasien IMA merupakan prediktormorbiditas risiko hampir 3 kali lipat (HR =2,578,IK 95% = 1,278 sampai 5,199, P=0,008), prediktorsyok kardiogenik sebesar 15 kali lipat (HR =15,231, IK 95% = 1,848 sampai 700,579,P=0,0014) danprediktor gagal jantung 5 kali lipat (HR=5,269, IK 95% = 1,913 sampai 15,796,P=0,0002) dibandingkanpasien tanpa hiperlaktasemia. Hiperlaktasemia tidak terbukti sebagai prediktor aritmia(HR = 1,35,IK 95% = 0,344 sampai 4,627, P=0,3051).Hiperlaktasemia merupakan prediktor independen morbiditas,syok kardiogenik, dan gagal jantung pada pasien IMA. Hiperlaktasemia tidak terbukti sebagai prediktorindependen aritmia pada pasien IMA. [MEDICINA 2015;46:71-6]."

### Keywords
*Keyword Not Available*

### Downloads:
Download data is not yet available.

{% include adsense.html %}
## References
References Not Available

### PDF:

{% include adsense1.html %}

<https://jurnal.harianregional.com/medicina/full-18083>

{% include adsense2.html %}

### Published
2021-11-09

### How To Cite
BAGIARI, Ketut Erna; RINA, Ketut; ISWARI, Ida Sri.  HYPERLACTATEMIA AS PREDICTOR MORBIDITY IN ACUTE MYOCARDIAL INFARCTION.Medicina, [S.l.], v. 46, n. 2, jan. 2016. ISSN 2540-8321. Available at: <https://jurnal.harianregional.com/medicina/id-18083>. Date accessed: {{ site.time | date: "%d %b. %Y" }}.

## Citation Format
ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian

### Issue
Vol 46 No 2 (2015): Mei 2015

### Section 
**Articles**

### Copyright 
{% include inarticle.html %}
<a href="http://creativecommons.org/licenses/by/4.0/" rel="license"><img src="https://i.creativecommons.org/l/by/4.0/88x31.png" alt="Creative Commons License" /></a>
This work is licensed under aÂ <a href="http://creativecommons.org/licenses/by/4.0/" rel="nofollow">Creative Commons Attribution 4.0 International License</a>

{% include multiplex.html %}
